| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 9,828 | — | — | 9,828 | Apr 27, 2021 | Apr 29, 2021 ↗ |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 6,000 | — | — | 6,000 | Apr 27, 2021 | Apr 29, 2021 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | SALE | 55,991 | — | — | 0 | May 5, 2020 | May 6, 2020 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | SALE | 67,672 | — | — | 0 | May 5, 2020 | May 6, 2020 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASE | 6,404 | — | — | 55,064 | May 5, 2020 | May 6, 2020 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | SALE | 97,216 | — | — | 0 | May 5, 2020 | May 6, 2020 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,661 | $16.00 | $314.6K | 48,660 | May 1, 2020 | May 1, 2020 ↗ |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,500 | — | — | 14,500 | Apr 30, 2020 | May 1, 2020 ↗ |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 6,000 | — | — | 6,000 | Apr 28, 2020 | Apr 30, 2020 ↗ |
| TBPH THERAVANCE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 6,635 | — | — | 6,635 | Apr 28, 2020 | Apr 30, 2020 ↗ |